*To be consumed as directed by physician.
Therapies:
Biotech Product
Composition:
Bevacizumab (400 mg)
Cizumab 400 mg injection contains Bevacizumab, an anticancer medicine designed to prevent tumour growth. It is used alongside other chemotherapy drugs to treat various cancers, including metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, colorectal cancer, and cancers of the ovary, fallopian tube, or primary peritoneal cancer. Cizumab 400 Solution for Infusion is an anti-angiogenic medication. It blocks a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.
*To be consumed as directed by physician.